BRAF and melanoma: Because BRAF inhibitors also induce PGC-1α, a regulator of mitochondrial biogenesis that in turn causes OXPHOS upregulation (65), combining BRAF inhibitors and phenformin could have reduced the proliferation of BRAF-mutant melanoma cells and contribute to tumor regression in that study.